Cardioneuroablation for Vasovagal Syncope: Evidence and Technique

Vasovagal syncope is usually benign from a mortality perspective, yet recurrent episodes can cause injury, driving restrictions, lost employment, and substantial anxiety. For a carefully selected subgroup with a dominant cardioinhibitory response, cardioneuroablation (CNA) has emerged as a catheter-based strategy intended to reduce excessive vagal influence on the sinus and atrioventricular nodes. The approach is gaining attention as an alternative to permanent pacing in younger patients, although its role remains under active investigation.

CNA combines detailed electrophysiological mapping with targeted radiofrequency ablation of atrial ganglionated plexi. The procedure requires a clear diagnosis, an understanding of the mechanism of syncope, and realistic counselling about recurrence. For Australian clinicians, these decisions also sit within a health system where complex ablation is concentrated in metropolitan centres such as Sydney, Melbourne, Brisbane and Perth, while patients from regional and remote areas may face considerable travel for assessment and follow-up.

Selecting Patients With A Cardioinhibitory Mechanism

The strongest rationale for CNA exists when syncope is associated with documented asystole or profound bradycardia. Useful evidence may come from an implantable loop recorder, an induced cardioinhibitory response during head-up tilt testing, or a spontaneous event captured on an electrocardiogram. A careful history remains essential because a positive tilt test can reflect susceptibility to hypotension rather than a purely vagal pause.

CNA should not be offered simply because a patient has fainted recurrently. Initial evaluation should exclude structural heart disease, inherited arrhythmia syndromes, orthostatic hypotension, medication-related bradycardia and neurological mimics. Renal disease, autonomic dysfunction and diabetes can modify procedural risk and syncope mechanisms; clinicians may also find value in reviewing emerging sudden death markers when broader risk assessment is required.

Age and lifestyle influence the treatment discussion. A permanent pacemaker may prevent bradycardic episodes but introduces lead, generator and infection risks over a lifetime, particularly in a young adult. CNA aims to avoid an implanted device, yet the evidence base is less mature than for pacing in selected older patients with recurrent cardioinhibitory syncope. Shared decision-making should address both possibilities rather than presenting ablation as a guaranteed replacement for pacing.

What Current Evidence Shows

Prospective cohorts and small randomised studies have reported reductions in syncope recurrence after CNA, with improvements in sinus rate, atrioventricular conduction and autonomic balance. Several studies suggest that ablation can be effective in patients with documented asystolic vasovagal syncope, especially when the response is predominantly cardioinhibitory. However, study populations, mapping methods, ablation targets and definitions of success vary substantially.

The limitations are important. Many reports come from experienced high-volume centres, follow-up is often relatively short, and blinding is difficult in an invasive procedure. Recurrent fainting can also decline after education, hydration, physical counter-pressure manoeuvres and reassurance, making uncontrolled comparisons difficult to interpret. Long-term durability, the effect of ageing and the possibility of later pacemaker implantation remain incompletely defined.

Current evidence therefore supports CNA as a specialised option rather than routine therapy for all vasovagal syncope. In Australia, a patient may need referral from a general cardiologist or emergency department to a tertiary electrophysiology service, with local access depending on public waiting lists, private insurance and travel distance. Multidisciplinary review is particularly valuable when the diagnosis is uncertain or when hypotension coexists with bradycardia.

Mapping The Autonomic Targets

The principal targets are atrial ganglionated plexi located around the pulmonary vein antra, superior vena cava, interatrial septum, coronary sinus ostium and, in some techniques, the inferior vena cava region. These structures contain neural pathways that influence sinus node automaticity, atrioventricular nodal conduction and atrial refractoriness. Anatomical targeting may be guided by electrogram characteristics, fractionated potentials, high-frequency stimulation, spectral analysis or a combination of methods.

Ablation is generally performed from the right and left atria, often beginning with the right-sided plexi and then addressing left atrial sites. Operators must distinguish autonomic tissue from ordinary atrial myocardium and avoid unnecessary lesion delivery. Excessive ablation could create atrial tachycardia substrate, impair sinus node function, injure the phrenic nerve or increase the risk of pulmonary vein stenosis if lesions are delivered too distally.

There is no universally accepted endpoint. Elimination of fractionated electrograms, abolition of a vagal response during stimulation, shortening of the PR interval or an increase in sinus rate may support procedural success, but none alone proves durable autonomic denervation. A consistent protocol for mapping, stimulation and endpoint assessment is still needed before results can be compared reliably between centres.

Procedural Planning And Safety

Pre-procedure planning should include a complete rhythm history, echocardiography when indicated, baseline autonomic and orthostatic assessment, and review of drugs that lower blood pressure or heart rate. The team should document the index event in detail: posture, prodrome, duration, injury, recovery, documented rhythm and response to counter-pressure manoeuvres. A tilt-table study can be informative, but its results should be interpreted in the clinical context.

Intraprocedural anticoagulation is usually required for left atrial work, with vascular access, transseptal puncture and three-dimensional electroanatomical mapping adding their own risks. Potential complications include vascular injury, pericardial effusion, stroke or transient ischaemic attack, atrial tachyarrhythmia, pulmonary vein injury and inadvertent damage to the conduction system. A temporary pacing strategy and resuscitation capability are prudent, particularly when extensive vagal responses are anticipated.

Australian centres must also consider practical logistics. A patient travelling from Darwin, Cairns or regional New South Wales may need coordinated accommodation, transport and early post-procedure review. Consent should explain whether the procedure is being delivered within an established local protocol, a registry or a research study, and whether hospital and professional fees are covered through the public system, private insurance or self-funded care.

Relating CNA To Permanent Pacing

The appeal of CNA is clearest in younger patients who have recurrent, unpredictable, cardioinhibitory syncope but do not want lifelong device therapy. Permanent pacing remains relevant when spontaneous asystole is prolonged, episodes are traumatic, or ablation is unsuitable or unsuccessful. In older patients with documented bradycardia and a less prominent vasodepressor component, pacing may have a more established place.

Device therapy itself is not a simple endpoint. Lead extraction, generator replacement, venous occlusion and infection are clinically meaningful over time. The broader device literature illustrates why long-term surveillance matters: discussions of right bundle branch block and resynchronisation highlight that conduction patterns can affect device selection and outcomes. These issues are distinct from CNA but relevant when counselling a patient who may ultimately require pacing.

The comparison should include the haemodynamic component of reflex syncope. If a substantial fall in blood pressure precedes or accompanies the pause, eliminating vagal bradycardia may not prevent every episode. Education about fluid intake, salt intake where appropriate, physical counter-pressure manoeuvres and trigger avoidance remains necessary after CNA. In Australia, advice may need to account for hot summers, outdoor work, long-distance driving and the dehydration risk associated with sport or remote travel.

Assessing Outcomes And Recurrence

Follow-up should assess both symptoms and rhythm rather than relying on resting heart rate alone. Patients can record presyncope, syncope, posture, prodrome, injury, hydration, medication exposure and recovery time. Ambulatory monitoring or an implantable loop recorder may be appropriate when symptoms persist or the original mechanism was uncertain. Tilt testing can be repeated selectively, although a change in laboratory response does not always translate into clinical protection.

Recurrence does not automatically mean that CNA has failed. A patient may have a residual vasodepressor response, a new orthostatic problem, an inadequate target set or a non-reflex cause of syncope. Repeat electrophysiological assessment and autonomic review should precede decisions about repeat ablation or pacemaker implantation. Follow-up should also check for atrial arrhythmias, which may occur after atrial ablation and influence anticoagulation decisions.

When a patient later receives a pacemaker, ventricular pacing burden deserves attention. The experience of pacing-induced dysfunction reinforces the need to monitor ventricular function and consider programming or physiologic pacing strategies when appropriate. This is particularly relevant for younger patients, who may otherwise face decades of device exposure.

Building A Responsible Clinical Pathway

A responsible CNA programme should define referral criteria, diagnostic standards, mapping techniques, procedural endpoints and follow-up intervals before treatment begins. It should record syncope recurrence, presyncope, injury, hospital presentations, pacemaker implantation, atrial arrhythmia and quality-of-life measures. Consistent reporting will help clarify which patients benefit and whether early improvements persist over many years.

Training and case selection are central. The procedure combines complex atrial ablation, autonomic physiology, syncope evaluation and management of potential complications. It should be performed by an electrophysiology team with appropriate imaging, anaesthetic and surgical backup, rather than adopted solely because the technique is available. Participation in prospective registries or ethically approved studies can strengthen the evidence relevant to Australian practice.

Patients should receive a written management plan covering warning symptoms, hydration, driving and occupational advice, wound care, medication changes and emergency contacts. Australian driving rules are set through national standards but applied through individual licensing processes, so advice should be documented and revisited after recurrent events or treatment. Clear communication between the electrophysiologist, primary care clinician and referring cardiologist is especially important when care crosses state or regional boundaries.

For patients with documented cardioinhibitory vasovagal syncope, CNA is a promising technique that may reduce recurrent episodes and defer or avoid permanent pacing. Its benefits must be balanced against uncertain long-term durability, procedural risks and the possibility that hypotension will remain untreated. Clinicians can support better care by applying rigorous patient selection, transparent counselling and structured follow-up while contributing outcomes to the growing international evidence base. Submit carefully documented clinical research, reviews and case-based observations to the Journal of Arrhythmia to help refine autonomic ablation practice across the Asia-Pacific region.